Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)

Annals of Oncology

Volumn 12, Issue 5, 2001, Pages 675-679

  Louvet, C ^a   Andre T ^b   Hammel, P ^c   Selle, F ^b   Landi, B ^d   Cattan, S ^e   Fonck, M ^f   Flesch, M ^g   Colin, P ^h   Balosso, J ^b,i   Ruszniewski, P ^c   De Gramont, A ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL TENON   (France)

^c BEAUJON HOSPITAL   (France)

^d Hopital Laennec   (France)

^e HÔPITAL ROTHSCHILD   (France)

^f CLCC Bergonié   (France)

^g Fondation Drevon   (France)

^h Policlinique de Courlancy   (France)

ⁱ Clinical Research Group in Oncology   (France)

Author keywords

5 Fluorouracil; Advanced pancreatic cancer; Gemcitabine

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; BOLUS INJECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG INFUSION; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUTROPENIA; PANCREAS ADENOCARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0034993137     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011139808426     Document Type: Article

References (24)

1. National cancer prevalence estimation in France
2. Cancer of the pancreas
3. Cancer of the pancreas: 50 years of surgery
4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
5. Chemotherapy improves survival and quality of life in advanced pancreatic biliary cancer
6. Chemotherapy prolongs survival in inoperable pancreatic carcinoma
7. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
8. Efficacy of 5 FU + cisplatin (FUP) compared to bolus 5 FU (FU) in advanced pancreatic carcinoma: A randomized trial from the French Anticancer Centers Digestive Group (FNLCCDG)
9. Randomized trial comparing monthly low dose leucovorin and fluorouracil bolus with bimonthly high dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer
10. A simplified bimonthly regimen with leucovorin and 5-FU for metastatic colorectal cancer
11. Phase II trial of combined radiotherapy and chemotherapy as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma
12. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (60 Gy) radiation alone, moderate dose radiation (40 Gy) + 5-FU, and high dose radiation + 5-FU
13. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: A phase I ECOG trial
14. Phase II trial of gemcitabine in patients with adenocarcinoma of the pancreas
15. Phase II study of gemcitabine in patients with advanced pancreatic cancer
16. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer
17. A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
18. A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern cooperative oncology group study
19. Ex vivo ATP tumor testing of gemcitabine for combination chemotherapy and biochemical modulation
20. Phase I trial of gemcitabine (Gemzar), 24-h infusion 5-fluorouracil and leucovorin in patients with inoperable pancreatic cancer
21. Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: A clinical benefit-oriented phase II study
22. High dose 5-fluorouracil (FU) 24-h-infusion with gemcitabine (GEM). Tolerance and efficient in palliative outpatient treatment of pancreatic cancer
23. A phase I/II clinical and pharmacologic study of dose-escalating and dose-sequencing of administration of gemcitabine (G) and folinic acid (FA)/fluorouracil (FU) in advanced pancreatic cancer (APC)
24. Randomized phase II trial of dose intense gemcitabine by standard infusion vs. fixed dose rate in metastatic pancreatic adenocarcinoma